For research use only. Not for therapeutic Use.
MY33-3（Cat No.:I044380）is a selective inhibitor of leucine-rich repeat kinase 2 (LRRK2), a protein kinase implicated in the pathogenesis of Parkinson’s disease. By targeting LRRK2’s kinase activity, MY33-3 reduces phosphorylation of its substrates, thereby modulating cellular processes like vesicle trafficking, autophagy, and mitochondrial function. It has demonstrated neuroprotective effects in preclinical models, helping to prevent neuronal degeneration and inflammation. MY33-3 is valuable for exploring LRRK2-related disease mechanisms and supports therapeutic development for Parkinson’s and other neurodegenerative disorders where aberrant LRRK2 signaling plays a crucial role in disease progression.
| CAS Number | 2204280-41-9 |
| Synonyms | 1-[4-(trifluoromethylsulfanyl)phenyl]-N-[[4-(trifluoromethylsulfanyl)phenyl]methyl]methanamine |
| Molecular Formula | C16H13F6NS2 |
| Purity | ≥95% |
| IUPAC Name | 1-[4-(trifluoromethylsulfanyl)phenyl]-N-[[4-(trifluoromethylsulfanyl)phenyl]methyl]methanamine |
| InChI | InChI=1S/C16H13F6NS2/c17-15(18,19)24-13-5-1-11(2-6-13)9-23-10-12-3-7-14(8-4-12)25-16(20,21)22/h1-8,23H,9-10H2 |
| InChIKey | NRRCKCHDXWGUIH-UHFFFAOYSA-N |
| SMILES | C1=CC(=CC=C1CNCC2=CC=C(C=C2)SC(F)(F)F)SC(F)(F)F |
| Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |
